• 4414 Citations
  • 33 h-Index
1991 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Francesco Merli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 37 Similar Profiles
Hodgkin Disease Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Vincristine Medicine & Life Sciences
Prednisone Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Bleomycin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

  • 4414 Citations
  • 33 h-Index
  • 140 Article
  • 1 Letter

Atypical cutaneous lesions in advanced-stage Hodgkin lymphoma: A case report

Massaro, F., Ferrari, A., Zendri, E., Zanelli, M. & Merli, F., Sep 1 2019, In : World Journal of Clinical Cases. 7, 17, p. 2513-2518 6 p.

Research output: Contribution to journalArticle

Open Access
Hodgkin Disease
Skin
Biopsy
Dacarbazine
Axilla

Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)

Salvi, F., Luminari, S., Tucci, A., Massidda, S., Liberati, A. M., Stelitano, C., Zanni, M., Re, A., Centurioni, R., Freilone, R., Musuraca, G., Nassi, L., Patti, C., Arcari, A., Tani, M., Pulsoni, A., Pavone, V., Volpetti, S., Peli, A., Evangelista, A. & 3 others, Spina, M., Ladetto, M. & Merli, F., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Dacarbazine
Vinblastine
Bleomycin
Hodgkin Disease
Radiotherapy
1 Citation (Scopus)

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Luminari, S., Merli, M., Rattotti, S., Tarantino, V., Marcheselli, L., Cavallo, F., Varettoni, M., Bianchi, B., Merli, F., Tedeschi, A., Cabras, G., Re, F., Visco, C., Torresan Delamain, M., Cencini, E., Spina, M., Ferrero, S., Ferrari, A., Deodato, M., Mannina, D. & 7 others, Annibali, O., Rago, A., Orsucci, L., Defrancesco, I., Frigeni, M., Cesaretti, M. & Arcaini, L., Sep 5 2019, In : Blood. 134, 10, p. 798-801 4 p.

Research output: Contribution to journalArticle

Disease Progression
Lymphoma
Survival
B-Cell Lymphoma
Follicular Lymphoma

Home care of acute leukaemia patients: From active therapy to end-of-life and palliative care. The 3-year experience of a single centre

Capodanno, I., Tamagnini, E., Alfieri, P., Codeluppi, K., Luminari, S. & Merli, F., Jan 1 2019, In : European Journal of Haematology.

Research output: Contribution to journalArticle

Terminal Care
Home Care Services
Palliative Care
Leukemia
Hospitalization

Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi

Merli, F., Cavallo, F., Salvi, F., Tucci, A., Musuraca, G., Nassi, L., Merli, M., Tani, M., Gini, G., Ferrari, A., Molinari, A. L., Liberati, A. M., Conconi, A., Matteucci, P., Bari, A., Scalone, R., Ferrero, S., Zanni, M., Mammi, C. & Luminari, S., Jan 1 2019, In : Journal of Geriatric Oncology.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Confidence Intervals
Geriatric Assessment
Safety
obinutuzumab